Clough Capital Partners L P Talaris Therapeutics, Inc. Transaction History

Clough Capital Partners L P

  • $924 Million
  • Q3 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 15, 2021
SELL
$11.61 - $15.99 $390,096 - $537,264
-33,600 Closed
0 $0
Q2 2021

Aug 16, 2021
BUY
$12.25 - $18.61 $411,600 - $625,296
33,600 New
33,600 $494,000

Others Institutions Holding TALS

# of Institutions
3
Shares Held
75.7K
Call Options Held
0
Put Options Held
0
View Full List

About Talaris Therapeutics, Inc.

TALS Quotes by TradingView
  • Ticker TALS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,995,900
  • Market Cap $109M
  • Description
  • Talaris Therapeutics, Inc. operates as a late-clinical stage cell therapy company in the United States. The company engages in developing a method of allogeneic hematopoietic stem cell transplantation to transform the standard of care in solid organ transplantation and severe autoimmune diseases, as well as severe non-malignant blood, immune, an...
More about TALS
Track This Portfolio

Track Clough Capital Partners L P Portfolio

Follow Clough Capital Partners L P and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Clough Capital Partners L P, based on Form 13F filings with the SEC.

News

Stay updated on Clough Capital Partners L P with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email